Skip to main content


Fig. 5 | Clinical Epigenetics

Fig. 5

From: A novel method for isolation of histones from serum and its implications in therapeutics and prognosis of solid tumours

Fig. 5

Schematic representation of liquid biopsy as tool for better clinical management of cancer patients. The DAE protocol provides ‘real-time’ purification of serum histones and monitoring of levels of chromatin modifiers like HDACs and HATs that will help in subgrouping patients eligible for epi-drug treatment and their response, aid in better prognosis and disease management

Back to article page